Oragenics Inc SEC filings OGEN
Oragenics Inc has 1,003 filings in SEC EDGAR's recent list, going back to Jun 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 20, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| EFFECT | Filing | Jun 30, 2025 | — |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| DRS | Filing | Jun 3, 2025 | — |
| DRSLTR | Filing | Jun 2, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| CORRESP | Letter to the SEC | Apr 11, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2025 | — |
| RW | Filing | Feb 4, 2025 | — |
| EFFECT | Filing | Jan 16, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Dec 31, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2024 | — |
| EFFECT | Filing | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| CORRESP | Letter to the SEC | Sep 3, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2024 | — |
| D | Filing | Aug 8, 2023 | — |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Jan 25, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2022 | — |
| CORRESP | Letter to the SEC | Jul 29, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2022 | — |
| EFFECT | Filing | Jun 30, 2020 | — |
| CORRESP | Letter to the SEC | Jun 26, 2020 | — |
| CORRESP | Letter to the SEC | Jun 19, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2020 | — |
| D | Filing | May 6, 2020 | — |
| EFFECT | Filing | Jan 13, 2020 | — |
| CORRESP | Letter to the SEC | Jan 9, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2020 | — |
| EFFECT | Filing | Jul 12, 2018 | — |
| CORRESP | Letter to the SEC | Jul 11, 2018 | — |
| CORRESP | Letter to the SEC | Jul 11, 2018 | — |
| UPLOAD | Letter from the SEC | May 23, 2018 | — |
| EFFECT | Filing | May 8, 2018 | — |
| CORRESP | Letter to the SEC | May 4, 2018 | — |
| UPLOAD | Letter from the SEC | May 4, 2018 | — |
| D | Filing | Apr 12, 2018 | — |
| D | Filing | Nov 14, 2017 | — |
| CT ORDER | Filing | Jun 29, 2017 | — |
| D | Filing | May 19, 2017 | — |
| EFFECT | Filing | Sep 7, 2016 | — |
| CORRESP | Letter to the SEC | Sep 2, 2016 | — |
| CORRESP | Letter to the SEC | Sep 1, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2016 | — |
| D | Filing | Jul 13, 2016 | — |
| CT ORDER | Filing | Aug 5, 2015 | — |
| CT ORDER | Filing | Nov 12, 2013 | — |
| D | Filing | Oct 15, 2013 | — |
| EFFECT | Filing | Aug 26, 2013 | — |
| EFFECT | Filing | May 2, 2013 | — |
| CORRESP | Letter to the SEC | Apr 29, 2013 | — |
| CORRESP | Letter to the SEC | Apr 25, 2013 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2013 | — |
| CERTNYS | Auto-generated paper document | Apr 9, 2013 | — |
| 8-A12B | Form 8a | Apr 8, 2013 | — |
| EFFECT | Filing | Sep 26, 2012 | — |
| D | Filing | Aug 10, 2012 | — |
| D | Filing | Aug 10, 2012 | — |
| CT ORDER | Filing | Aug 3, 2012 | — |
| D | Filing | Jun 15, 2012 | — |
| D | Filing | Apr 5, 2012 | — |
| NT 10-K | Notification of late filing | Apr 2, 2012 | Dec 31, 2011 |
| UPLOAD | Letter from the SEC | Jan 9, 2012 | — |
| CORRESP | Letter to the SEC | Dec 20, 2011 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2011 | — |
| RW | Request for withdrawal | Dec 22, 2010 | — |
| D | Filing | Aug 11, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2010 | — |
| CORRESP | Letter to the SEC | Jul 7, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2010 | — |
| EFFECT | Filing | Apr 13, 2010 | — |
| EFFECT | Filing | Apr 13, 2010 | — |
| EFFECT | Filing | Apr 13, 2010 | — |
| EFFECT | Filing | Apr 13, 2010 | — |
| D | Filing | Jan 13, 2010 | — |
| EFFECT | Filing | Nov 16, 2009 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2009 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2009 | — |
| NT 10-Q | Filing | May 15, 2009 | Mar 31, 2009 |
| NT 10-K | Filing | Apr 1, 2009 | Dec 31, 2008 |
| 25-NSE | Delisting notice | Jan 14, 2009 | — |
| 10KSB | Form 10-ksb | Mar 18, 2008 | Dec 31, 2007 |
| 10QSB | Form 10qsb | Nov 14, 2007 | Sep 30, 2007 |
| EFFECT | Filing | Sep 26, 2007 | — |
| 10QSB | Form 10-qsb | Aug 13, 2007 | Jun 30, 2007 |
| EFFECT | Filing | Jul 2, 2007 | — |
Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Lakewood Ranch, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1174940
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.